The first author’s name appears incorrectly in the article citation. The correct citation is: Wittenberg Dreazen A, Azar S, Klochendler A, Stolovich-Rain M, Avraham S, Birnbaum L, et al. (2016) Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells. PLoS ONE 11(2): e0149995. doi:10.1371/journal.pone.0149995.

Table 1 appears incorrectly in the published article. The last six rows are duplicates of the six above them. Please see the correct Table 1 and its caption below. The publisher apologizes for the error.

Download:

• PPT
  PowerPoint slide
• PNG
  larger image
• TIFF
  original image

Table 1. List of proteins that selectively interact with unphosphorylatable form of rpS6.

Whole cell extract from HEK293 cells infected with pS6^[5S]-GFP, pS6^[5A]-GFP, pS6^[5D]-GFP or pEGFP-N1, was subjected to GFP pull-down, and the bound proteins were size fractionated by SDS-polyacrlamide gel electrophoresis. Mass spectrometric analysis of proteins in each lane was performed as described in “material and Methods” and proteins, selectively bound to pS6^[5A]-GFP in two independent experiments, are presented (numbers separated by slash [/] represent results obtained in each of the two individual analyses).

https://doi.org/10.1371/journal.pone.0155281.t001